NeuroVive Pharmaceutical AB announced the appointment of Daniel Schale as Director of Communications. Daniel will report to CFO Catharina Johansson. Daniel Schale will be responsible for the company's communications, media relations and public affairs. Daniel has ten years of experience in PR and communications, in recent years with special focus on pharmaceuticals, biotech and life science. Daniel joins NeuroVive from a role as senior corporate communications and public affairs advisor with Aspekta. Having been responsible for clients in the pharmaceutical and life science industries, Daniel has worked with lobbying, advocacy and disease awareness, as well as market access communications.